Orthofix Medical (OFIX) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Orthofix Medical | 375.38 Mn | 254.51 Mn | 139.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.92% |
| Dec 31, 2025 | 4.44% |
| Sep 30, 2025 | -10.74% |
| Jun 30, 2025 | -7.97% |
| Mar 31, 2025 | -28.29% |
| Dec 31, 2024 | 14.72% |
| Sep 30, 2024 | -0.13% |
| Jun 30, 2024 | -0.87% |
| Mar 31, 2024 | -78.06% |
| Dec 31, 2023 | -18.30% |
| Sep 30, 2023 | -50.34% |
| Jun 30, 2023 | -18.46% |
| Mar 31, 2023 | -57.06% |
| Dec 31, 2022 | -39.86% |
| Sep 30, 2022 | -15.91% |
| Jun 30, 2022 | -22.74% |
| Mar 31, 2022 | 6.69% |
| Dec 31, 2021 | -10.65% |
| Sep 30, 2021 | -17.69% |
| Jun 30, 2021 | -16.33% |
| Mar 31, 2021 | -12.08% |
| Dec 31, 2020 | 5.48% |
| Sep 30, 2020 | 4.47% |
| Jun 30, 2020 | 22.42% |
| Mar 31, 2020 | 37.42% |
| Dec 31, 2019 | -4.71% |
| Sep 30, 2019 | -8.28% |
| Jun 30, 2019 | -19.69% |
| Mar 31, 2019 | 36.69% |
| Dec 31, 2018 | 6.85% |
| Sep 30, 2018 | -2.32% |
| Jun 30, 2018 | -2.76% |
| Mar 31, 2018 | -17.47% |
| Dec 31, 2017 | 20.23% |
| Sep 30, 2017 | 5.29% |
| Jun 30, 2017 | -6.57% |
| Mar 31, 2017 | -17.32% |
| Dec 31, 2016 | -3.83% |
| Sep 30, 2016 | 1.00% |
| Jun 30, 2016 | 29.32% |
| Mar 31, 2016 | -24.37% |
| Dec 31, 2015 | 6.33% |
| Sep 30, 2015 | 11.50% |